(2021). Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Efficacy and Safety of Nitazoxanide Plus Atazanavir/ritonavir for the Treatment of Moderate to Severe COVID-19 (NACOVID): A Structured Summary of a Study Protocol for a Randomised Controlled Trial. 2021.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Efficacy and Safety of Nitazoxanide Plus Atazanavir/ritonavir for the Treatment of Moderate to Severe COVID-19 (NACOVID): A Structured Summary of a Study Protocol for a Randomised Controlled Trial. 2021.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.